Publication | Closed Access

3004 ORAL Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) in the first-line treatment of metastastic colorectal cancer (mCRC): a large-scale phase II study, OPUS

Metastastic Colorectal CancerGastrointestinal OncologyMedicineCancer ManagementColorectal CancerPathologyFirst-line TreatmentCancer TreatmentOncologyRadiation OncologyCancer ResearchMolecular OncologyOral Cetuximab